NCT03961308View on ClinicalTrials.gov

A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

October 20, 2018

Study Completion Date

November 21, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Vedolizumab SC

Vedolizumab SC liquid.

Trial Locations (2)

68502

Celerion, Lincoln

85283

Celerion, Tempe

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03961308 - A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy Participants | Biotech Hunter | Biotech Hunter